US Stock MarketDetailed Quotes

Immunovant (IMVT)

Watchlist
  • 37.360
  • -0.740-1.94%
Close Sep 11 16:00 ET
  • 36.830
  • -0.530-1.42%
Post 19:30 ET
7.72BMarket Cap-13.30P/E (TTM)

Immunovant (IMVT) Earnings Dates, Reports & Conference Call

IMVT 2027 Q1 Estimated Earnings Dates & Summary

Currency:USDAug 6, 2026

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Net Income
-130.96M
-153.22M
-22.26M
Miss Est.
-8.58%
-27.04%
-17.00%
EPS
-0.632
-0.75
-0.118
Miss Est.
+11.00%
-5.63%
-18.69%
Strong Buy

Sep 11, 2026

IMVT Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2027/Q3-- / 0.000--
--2027/Q2-- / 0.000--
Aug 6, 20262027/Q10.000 / 0.000--
May 20, 20262026/Q40.000 / 0.000--
Feb 6, 20262026/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2027/Q3-- / 0.000--
--2027/Q2-- / 0.000--
Aug 6, 20262027/Q10.000 / 0.000--
May 20, 20262026/Q40.000 / 0.000--
Feb 6, 20262026/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More